Video

Newly Discovered Biomarker May Help Personalize Colorectal Cancer Treatment

Author(s):

Martin D. Berger, M.D.

Researchers might be on to a new biomarker for patients with colorectal cancer, says Martin D. Berger, M.D., oncologist at the University of Southern California.

Researchers might be on to a new biomarker for patients with colorectal cancer, says Martin D. Berger, M.D., oncologist at the University of Southern California.

In a phase 3 trial conducted in Europe, 300 patients with metastatic colorectal cancer were assigned a treatment regimen of FOLFIRI plus bevacizumab, while 300 other patients — who had the same staging and type of disease – were given FOLFIRI plus cetuximab. The patients who had the genetic mutation to transport vitamin C had better outcomes and survival on the FOLFIRI plus bevacizumab regimen, while survival for patients with and without this mutation was the same for the group given FOLFIRI and cetuximab.

Findings like these, paired with further investigation, may lead to better personalizing treatment for patients with metastatic colorectal cancer.

Related Videos
Image of a man with dark hair and some facial hair.
Image of a man with blond facial hair.
Image of woman with blonde hair.
Image of a woman with long red hair.
Image of a man in a suit.
Image of woman with brown hair.
Image of a man with short hair, wearing a buttoned-up shirt.
Image of a man with short black hair.
Image of a woman with tied back hair, wearing pearl earrings.
Related Content
Woman putting on compression stockings on swollen feet affected by lymphedema condition: © Julia - stock.adobe.com
November 13th 2024

Lymphedema Myths and Misconceptions, From Exercise to Blood Draws

Alex Biese
An expert explains how attitudes towards lymphedema risk have evolved over the years.
Teri Greige with medals
February 16th 2023

The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer

Brielle Benyon
Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.
A female doctor sits at a table in a hospital, discussing intestinal health issues, including appendicitis, colon cancer symptoms, diarrhea,constipation, blood in stool, unexplained weight loss.
November 11th 2024

Ponsegromab May Aid Weight Gain in Patients With Cachexia

Spencer Feldman
Ponsegromab helped patients with cachexia and elevated GDF-15 levels gain weight, increase activity and improve cachexia symptoms, with manageable safety.
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
January 27th 2022

‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC

Jamie Cesanek
In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.
Image of a cartoon colon with a stethoscope around it on a pink background.
November 8th 2024

James Van Der Beek Opens Up About Colorectal Cancer, U.S. Congressman Reveals Cancer Diagnosis and More

Ashley Chan
From James Van Der Beek spreading awareness about colorectal cancer at a younger age to Gerry Connolly’s recent esophageal cancer diagnosis, here’s what’s happening in the cancer space this week.
Image of a colorectal cancer cell.
Published: November 7th 2024 | Updated: November 8th 2024

James Van Der Beek Has Colorectal Cancer, a Disease on the Rise in Younger Adults

Alex Biese
Rates of colorectal cancer diagnoses and deaths are climbing among patients younger than 55, researchers have shown.